PRF1 and neoplasm: CAR T cells can kill antigen-expressing tumor cells via the release of cytotoxic granules containing perforin and granzymes, through the Fas-FasL pathway, and by sensitizing the tumor stroma following the release of pro-inflammatory cytokines [5•].